A randomized, controlled study of autologous therapy with bone marrow–derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia - Concepedia

Concepedia

Publication | Closed Access

A randomized, controlled study of autologous therapy with bone marrow–derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia

71

Citations

33

References

2011

Year

Emerson C. Perin, Guilherme Silva, Amir Gahremanpour, John Canales, Yi Zheng, Maria G. Cabreira‐Hansen, Farrell O. Mendelsohn, Nicolas Chronos, Rebecca Haley, James T. Willerson,

Catheterization and Cardiovascular Interventions

Abstract

Administration of autologous ALDH(br) cells appears to be safe and warrants further study in patients with CLI.

References

	Year	Citations

Page 1